Aeras Global TB Vaccine Foundation

Patent Applications and Registrations

Patent applications and USPTO patent grants for Aeras Global TB Vaccine Foundation.The latest application filed is for "recombinant mycobacterium encoding a heparin-binding hemagglutinin (hbha) fusion protein and uses thereof".

Company Profile

1.20.6

Aeras Global TB Vaccine Foundation - Rockville MD US
Aeras Global TB Vaccine Foundation - Bethesda MD US
Aeras Global TB Vaccine Foundation - Crucell Holland B.V.

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Tuberculosis compositions and methods of using the same Grant 10,266,574 - Anantha , et al.	2019-04-23
Stable, spray dryed, immunogenic, viral compositions Grant 9,610,343 - Jin , et al. April 4, 2	2017-04-04
Recombinant Mycobacterium Encoding A Heparin-Binding Hemagglutinin (HBHA) Fusion Protein And Uses Thereof App 20150291669 - Fulkerson; John ; et al.	2015-10-15
Tuberculosis Compositions And Methods Of Using The Same App 20140377300 - Anantha; Ravi ; et al.	2014-12-25
Malaria vaccine compositions and constituents which elicit cell mediated immunity Grant 8,728,492 - Shafferman , et al. May 20, 2	2014-05-20
Methods to increase transgene expression from bacterial-based delivery systems by co-expressing suppressors of the eukaryotic type I interferon response Grant 8,658,136 - Sadoff , et al. February 25, 2	2014-02-25
Multivalent vaccines comprising recombinant viral vectors Grant 8,609,402 - Havenga , et al. December 17, 2	2013-12-17
Methods To Increase Transgene Expression From Bacterial-Based Delivery Systems By Co-Expressing Suppressors Of The Eukaryotic Type I Interferon Response App 20130224242 - Sadoff; Jerald C. ; et al.	2013-08-29
Methods to increase transgene expression from bacterial-based delivery systems by co-expressing suppressors of the eukaryotic type I interferon response Grant 8,414,884 - Sadoff , et al. April 9, 2	2013-04-09
Recombinant BCG tuberculosis vaccine designed to elicit immune responses to mycobacterium tuberculosis in all physiological stages of infection and disease Grant 8,361,482 - Shafferman , et al. January 29, 2	2013-01-29
Multivalent vaccines comprising recombinant viral vectors Grant 8,202,723 - Havenga , et al. June 19, 2	2012-06-19
Multivalent vaccines comprising recombinant viral vectors App 20110281347 - Havenga; Menzo Jans Emco ; et al.	2011-11-17
Bacterial packaging strains useful for generation and production of recombinant double-stranded RNA nucleocapsids and uses thereof Grant 8,053,568 - Hone , et al. November 8, 2	2011-11-08
Recombinant BCG strains with enhanced ability to escape the endosome Grant 8,043,857 - Sun , et al. October 25, 2	2011-10-25
Multivalent vaccines comprising recombinant viral vectors App 20110256166 - Havenga; Menzo Jans Emco ; et al.	2011-10-20
Multivalent vaccines comprising recombinant viral vectors Grant 8,012,467 - Havenga , et al. September 6, 2	2011-09-06
Generation of new BCG vaccine strains protecting against the establishment of latent Mycobacterium tuberculosis infection and reactivation from the latent or persistent state Grant 7,935,354 - Flores-Valdez , et al. May 3, 2	2011-05-03
Methods to increase transgene expression from bacterial-based delivery systems by co-expressing suppressors of the eukaryotic type I interferon response Grant 7,883,696 - Sadoff , et al. February 8, 2	2011-02-08
Electroporation of Mycobacterium and overexpression of antigens in mycobacteria Grant 7,829,104 - Sun , et al. November 9, 2	2010-11-09
Recombinant BCG tuberculosis vaccine designed to elicit immune responses to Mycobacterium tuberculosis in all physiological stages of infection and disease Grant 7,670,609 - Shafferman , et al. March 2, 2	2010-03-02
Recombinant BCG strains with enhanced ability to escape the endosome App 20100047286 - Sun; Ronggai ; et al.	2010-02-25
Recombinant BCG strains with enhanced ability to escape the endosome Grant 7,666,656 - Sun , et al. February 23, 2	2010-02-23
Transformed bacterium lacking selectable marker and overexpression of antigens in mycobacteria Grant 7,625,572 - Sun , et al. December 1, 2	2009-12-01
Methods to increase transgene expression from bacterial-based delivery systems by co-expressing suppressors of the eukaryotic type I interferon response Grant 7,608,256 - Sadoff , et al. October 27, 2	2009-10-27
Webbed immunogens comprising recombinant human immunodeficiency virus (HIV) envelope glycoproteins and the M9 scorpion toxin Grant 7,537,769 - Hone , et al. May 26, 2	2009-05-26

Company Registrations

NCAGE Code	SDPJ6	AERAS GLOBAL TB VACCINE FOUNDATION
CAGE Code	SDPJ6	AERAS GLOBAL TB VACCINE FOUNDATION

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.